antipsychotics | CARLAT PUBLISHING

Psychiatric Medication-Induced Hyperprolactinemia

October 30, 2022

Medication–induced hyperprolactinemia is more common than you might think and it can produce detrimental long-term health sequelae. In this podcast, we will review the work-up and management of this common side effect.

Throwback Thursday: Do Antipsychotics Improve Cognition?

October 6, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Are newer antipsychotics better for cognition than their older, typical forbearers?

CLINICAL UPDATE

Who's Who? A Review of Delusional Misidentification Syndromes

October 1, 2022

Adrienne Grzenda, MD, PhD.

Adrienne Grzenda, MD. Clinical Assistant Professor of Psychiatry & Biobehavioral Sciences, UCLA David Geffen School of Medicine and Olive View UCLA Medical Center, Los Angeles, CA.

Dr. Grzenda, author for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

You have probably encountered patients who adamantly insist a loved one has been replaced by an impostor. Here are tips for how to treat them.

Psychosis During Depression

August 23, 2022

Conrad M. Swartz, MD, PhD

Conrad M. Swartz, MD, PhD

Professor Emeritus, Southern Illinois University, Springfield, IL.

Dr. Swartz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Psychotic depression is difficult to detect, and antipsychotics are not as effective in this condition as we’d like to think. Conrad Swartz explains why 1 in 3 cases of psychotic depression are missed, its complex relationship to trauma, and how to treat it.

CLINICAL UPDATE

Six Tips From Prescribing Psychotropics

August 1, 2022

Chris Aiken, MD

Chris Aiken, MD.

Editor-in-Chief of The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken, author for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

New answers to age-old questions, such as adjusting the dose to account for drug interactions, reducing side effects, maintaining weight, and protecting that finicky organ—the kidneys.

Psychiatric Medication–Induced Hyperprolactinemia

July 1, 2022

Niki Karavitaki, MD. Senior Clinical Lecturer, Institute of Metabolism and Systems Research, University of Birmingham. Honorary Consultant Endocrinologist, Queen Elizabeth Hospital. Birmingham, UK.

Athanasios Fountas, MD. Clinical Research Fellow, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham. Birmingham, UK.

Dr. Karavitaki has disclosed that she has given webinars for Pfizer on the topic of acromegaly in February 2021 and January 2022. Dr. Hendrick has reviewed the content of this interview and determined that there is no commercial bias as a result of these financial relationships. Dr. Fountas has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Medication–induced hyperprolactinemia is more common than you might think and it can produce detrimental long-term health sequelae. Two endocrinologists -- Drs Fountas and Karavitakis – review the work-up and management of this common side effect.

Quetiapine Reconsidered

June 1, 2022

Paul Riordan, MD.

Paul Riordan, MD. Assistant Consulting Professor of Psychiatry, Duke University.

Dr. Riordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

It is the best of drugs; it is the worst of drugs. Quetiapine (Seroquel) has a few benefits that are unmatched by other medications, and here we explore where it fits in depression, bipolar, schizophrenia, as well as off-label uses like anxiety and sleep.

Vitamin B6 Lowers Prolactin on Antipsychotics

March 4, 2022

Brian Miller, MD, PhD, MPH.

Brian Miller, MD, PhD, MPH. Dr. Miller has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Higher antipsychotic doses are more likely to elevate prolactin. Enter: Vitamin B6.

Lybalvi: The Diet Olanzapine

January 31, 2022

Chris Aiken, MD.

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report

Lybalvi hopes to lower the risk of weight gain on olanzapine by combining it with an opioid blocker (samidorphan). But how does it compare to generic options like metformin and naltrexone?

Quetiapine in Bipolar With OCD

January 4, 2022

Richard Moldawsky, MD.

Richard Moldawsky, MD. Dr. Moldawsky has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

OCD and bipolar disorder often occur together, and this randomized controlled trial looks at whether quetiapine can treat this comorbidity.

Items Tagged with 'antipsychotics'

ARTICLES

Psychiatric Medication-Induced Hyperprolactinemia

Throwback Thursday: Do Antipsychotics Improve Cognition?

Who's Who? A Review of Delusional Misidentification Syndromes

Psychosis During Depression

Six Tips From Prescribing Psychotropics

Psychiatric Medication–Induced Hyperprolactinemia

Quetiapine Reconsidered

Vitamin B6 Lowers Prolactin on Antipsychotics

Lybalvi: The Diet Olanzapine

Quetiapine in Bipolar With OCD

Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

Using SAMe In Clinical Practice with Garrett Rossi, MD

Antidepressants and Bipolar at the Mood Summit

About

Shop Online

Newsletters

Contact

Follow Us